The goal of such therapy is not to cure but to improve the quality of life for both the person and their family. Evidence as of 2016 supports improvement in the quality of life. It focuses on providing people with relief from the symptoms, pain, physical stress, and mental stress of the terminal diagnosis in life-limiting diseases like Cancer. Medications and treatments are found to have a palliative effect if they relieve symptoms without having a therapeutic effect on the underlying disease or cause. Given in addition to cancer treatment, when a patient reaches a point where the cure is not warranted, palliative care becomes the sole focus of care. The respective session of the Cancer Therapy Conference will deal with issues like the difference between hospice care and palliative care, oncology nursing, pain management, psychosocial and emotional care on a spiritual level.
One of the major categories of cancer treatment methodologies, chemotherapy is the use of anticancer drugs or chemotherapeutic agents that inhibit mitosis of the cancerous cells. The intracellular poisons are infused into the body via various methods. The following session of the Cancer Therapy Conference shall involve how to enhance the methods of the chemo regime such that the side-effects can be minimized.
This strategy is generally used along with other treatments if the hormones interfere with cancer. Also known as Endocrine therapy, its administration methods can be oral vaccination or surgical depending on the type of cancer. This session of the Oncology Conference will be about how organ removal or hormonal blockage affects people and advancements in the scientific field about reducing its side effects.
A therapeutic strategy in which apoptosis-inducing transgenes are introduced into the cancerous cells, i.e. cell suicide is promoted into the cells that turn cancerous. Current cancer treatments create profound iatrogenic consequences. In this Cancer Therapy Conference, the point to be discussed is the adverse effects of the treatments that still remain, as the serious problems that practicing physicians have to cope with in clinical practice. Although non-specific cytotoxic agents constitute an effective treatment modality against cancer cells, they also tend to kill normal, quickly dividing cells. Suicide gene therapy is a new milestone in the medical world of cancer treatment that seems to have a promising future.
Radiotherapy uses high doses of radiation to shrink tumors and kill/ reduce the growth of cancer cells but damaging their DNA. The types of radiation therapy are various and it is capable of tackling metastatic cancers as well. This specific session of the Oncology Conference shall deal with the different methods of radiotherapy; which procedure is suitable for which type of cancer, radiopharmaceuticals, and many other such aspects.
A modernized version of pharmacotherapy that blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, unlike conventional chemotherapy that interferes with all rapidly dividing cells. Molecular Targeted Therapy is the expected to be a more effective method therapeutically and less harmful to the normal cells in the body. This particular session of the Cancer Treatment Conference shall emphasize the targeted therapies for various types of cancers and how its effectiveness is greater compared to the rest of the conventional treatments.
A biological therapy that enhances the immune system of the body to fight cancer. Monoclonal antibodies, cytokines, adoptive cell transfer, treatment vaccines, Bacillus Calmette-Guérin or BCG are few of the major soldiers for this purpose. Methods of immunotherapy, its effects, side effects, and advancements shall be the broader discussion area for this session of this Cancer Therapy Conference.
Transplantation of Stem Cells does not literally act “against” cancer; instead, they help recover the ability to produce stem cells after treatment with very high doses of radiation therapy, chemotherapy, or both. HCT (Haematopoietic Stem Cell Transplantation) is considered to be a lifesaving procedure in recent times. Thus, how to improvise the method for the betterment of the patients suffering from this lethal disease is a major concern and is to be a hot topic at the Oncology Conference.
Regenerative medicines are a branch of translational research that includes the ability to grow tissues and organs in the laboratory and implanting them when the body cannot heal itself to establish normal functioning of the body. The advancements in the field are vast as extracellular matrix materials are now commercially available and are used in reconstructive surgery, treating chronic wounds as well as some orthopedic surgeries; as the reports of January 2017 clinical studies, it was underway to use them in heart surgery to repair damaged heart tissue. This session at the Cancer Therapy 2018 Conference shall be about the future prospects and vital improvisations that can be brought about for this therapeutic process.
Incidence is the total number of new cases of cancer. Mortality is the number of deaths due to cancer. To provide the most current cancer statistics, researchers use the most up-to-date data available and statistical methods to estimate the number of new cancer cases and deaths for the current year.An estimated 206,200 new cases of cancer and 80,800 deaths from cancer occurred in Canada in 2018. (The number of estimated new cases does not include non-melanoma skin cancer cases.)Cancer is the leading cause of death in Canada and is responsible for 30% of all deaths.
The cancer research communities now believe that a cure is likely to emerge not only from pure biomedical research but from the intersection of cancer biology, mathematics, machine learning, and data analytics. So it might not be surprising in today’s date to find a data scientist leading a team of researchers, scientists and developers to find the drugs to effectively treat – and ultimately defeat – cancer. Big Data Analytics in cancer therapy shall set a milestone in this Cancer Therapy Conference.